Amgen collected domestic licenses of 3 biomedicines from GSK
Amgen, which officially established a Korean branch, collected domestic licenses of 3 biomedicines that were handed to GSK. They are blockbuster drugs which globally recorded USD 3.3 billion(approximately KRW 3.7 trillion) last year.
The company extended its pipelines to sell in Korea as securi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
